Zaccardelli David's Form 4 filing
Verona Pharma plc (VRNA) · filed Dec 2, 2024
- Accession no.
- 0001104659-24-124756
- Filed
- Dec 2, 2024
- Trade date
- Nov 27-Dec 2, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $627.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zaccardelli DavidCIK 0001627642 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Ordinary Shares | SSaleDisposed | −23,240 | $5.00 | −$116,200 | 15,177,512 | Direct | |
| Nov 29, 2024 | Ordinary Shares | SSaleDisposed | −98,888 | $5.01 | −$495,428.88 | 15,078,624 | Direct | |
| Dec 2, 2024 | Ordinary Shares | SSaleDisposed | −3,200 | $5.00 | −$16,000 | 15,075,424 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.